Search

Your search keyword '"Yamamoto, Masahide"' showing total 647 results

Search Constraints

Start Over You searched for: Author "Yamamoto, Masahide" Remove constraint Author: "Yamamoto, Masahide" Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
Sorry, I don't understand your search. ×
647 results on '"Yamamoto, Masahide"'

Search Results

2. Outcomes of transplant-eligible patients with myelodysplastic syndrome with excess blasts registered in an observational study: The JALSG-CS11-MDS-SCT

3. Deep convolutional neural network for differentiating between sarcoidosis and lymphoma based on [18F]FDG maximum-intensity projection images

14. Nationwide survey of systemic chronic active EBV infection in Japan in accordance with the new WHO classification

16. Clinical factors for central nervous system progression and survival in primary vitreoretinal lymphoma

17. A prospective trial of vaccine to prevent hepatitis B virus reactivation after hematopoietic stem cell transplantation

20. Clinical factors for central nervous system progression and survival in primary vitreoretinal lymphoma.

21. Outcomes of transplant-eligible patients with myelodysplastic syndrome with excess blasts registered in an observational study: The JALSG-CS11-MDS-SCT

24. Deep convolutional neural network for differentiating between sarcoidosis and lymphoma based on [18F]FDG maximum-intensity projection images

25. Lymphoproliferative disorder risk after methotrexate treatment for rheumatoid arthritis

26. Deep convolutional neural network for differentiating between sarcoidosis and lymphoma based on [18F]FDG maximum-intensity projection images.

28. Switching to nilotinib in patients with chronic myeloid leukemia in chronic phase with molecular suboptimal response to frontline imatinib: SENSOR final results and BIM polymorphism substudy

30. Outcomes of transplant-eligible patients with myelodysplastic syndrome with excess blasts registered in a prospective observational study: The JALSG-CS11-MDS-SCT

31. Phase II Study of a JAK1/2 Inhibitor Ruxolitinib for Systemic Chronic Active Epstein-Barr Virus Disease: An Investigator-Initiated Trial

35. Registry data analysis of hematopoietic stem cell transplantation on systemic chronic active Epstein–Barr virus infection patients in Japan

39. The Outcomes of Systemic Chronic Active EBV Infection Treatment By Allogeneic Hematopoietic Stem Cell Transplantation: An Analysis of Japanese Registry Data

40. Importance of the Duration of TKI Treatment in Treatment-Free Remission of Chronic Phase Chronic Myeloid Leukemia: Results of D-Free Trial

41. Outcomes of Transplant-Eligible Patients with Myelodysplastic Syndrome-Refractory Anemia with Excess Blasts Registered in a Prospective Observational Study: The JALSG-CS11-MDS-SCT

42. Nilotinib vs. imatinib in Japanese patients with newly diagnosed chronic myeloid leukemia in chronic phase: 10-year follow‑up of the Japanese subgroup of the randomized ENESTnd trial

45. An Antibody-Drug Conjugate That Selectively Targets Human Monocyte Progenitors for Anti-Cancer Therapy

Catalog

Books, media, physical & digital resources